--- title: Profil:临床开发的合作伙伴 description: 在临床开发针对糖尿病和肥胖症的新型解决方案方面Profil拥有世界顶尖的专业知识。 --- [![profil-logo-wortbild-with claim-4c-offset_1000px-1](https://www.profil.com/hs-fs/hubfs/profil-logo-wortbild-with%20claim-4c-offset_1000px-1.png?width=1000&name=profil-logo-wortbild-with%20claim-4c-offset_1000px-1.png "profil-logo-wortbild-with claim-4c-offset_1000px-1")](https://www.profil.com?hsLang=zh) [![Contact](https://no-cache.hubspot.com/cta/default/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da.png)](https://cta-redirect.hubspot.com/cta/redirect/481167/1f89c7d1-107f-4c8d-aa7b-f85d0dce14da) [Patient information](https://www.profil.de) ![Header_1077x400px_Clinical_development](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/Header/Header_1077x400px_Clinical_development.jpg?width=1077&height=400&name=Header_1077x400px_Clinical_development.jpg) # **临床开发** 您的临床开发合作伙伴。 ## 糖尿病药物的临床试验 Profil支持针对糖尿病、前驱糖尿病以及肥胖症等疾病新型解决方案临床开发所需的全部早期试验。我们的核心专业内容涵盖了糖尿病药物临床试验的所有基本方法，包括葡萄糖钳夹研究，药代动力学和药效学研究，安全性和耐受性研究以及生物等效性或桥接研究。在许多药物的发现项目过程中我们开展了数百项研究，我们的经验和知识使我们成为临床试验的理想合作伙伴。 我们的临床开发咨询团队将在试验设计的过程中协助您，以生成达到关键目标（例如在欧盟或北美进行产品注册或出口许可或者知识产权出售）所必需的数据。 请继续阅读更多有关我们在糖尿病治疗临床开发中提供的专业服务信息。 ![Clinical-Development_Content1.png](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/content-bilder/Clinical_Development/Clinical-Development_Content1.png?width=220&name=Clinical-Development_Content1.png "Clinical-Development_Content1.png") [**生物等效性和生物类似物** ``` 更多信息 ``` 让Profil支持您进行胰岛素生物类似物的临床试验。 ](https://www.profil.com/services/biosimilar?hsLang=zh) [**药效学** ``` 更多信息 ``` 关于您的药效学研究设计，请咨询Profil Germany。 ](https://www.profil.com/services/pharmacodynamics?hsLang=zh) [**药代动力学** ``` 更多信息 ``` 了解为什么Profil是药代动力学研究的完美合作伙伴。 ](https://www.profil.com/services/pharmacokinetics?hsLang=zh) [**桥接研究** ``` 更多信息 ``` 发现日本桥接研究的价值。 ](https://www.profil.com/services/bridging-study?hsLang=zh) [**安全性和耐受性** ``` 更多信息 ``` 阅读有关Profil的安全性和耐受性研究。 ](https://www.profil.com/services/safety?hsLang=zh) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_References.png?width=49&height=49&name=Icon_References.png) #### References We have published with the following sponsors: ![Referenzen](https://www.profil.com/hubfs/BLUE_MOON/content-bilder/Referenzen.gif "Referenzen") [View more](https://www.profil.com/knowledge-center/references?hsLang=zh) ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Certificates.png?width=44&height=49&name=Icon_Certificates.png) #### Certificates | ![13485_Zertifikatssiegel_black_A3](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_134852016_certificate_blue.png) ISO 13485:2016 ![27001_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_27001_certificate_.png) ISO 27001 | ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/ISO_9001-2015_certificate.png) ISO 9001:2015 ![9001:2015_Zertifikatssiegel](https://www.profil.com/hubfs/BLUE_MOON/piktos/BVMA_Logo_Certificate_size.png) BVMA Member | | --- | --- | ![blank.jpg](https://www.profil.com/hs-fs/hubfs/BLUE_MOON/piktos/Icon_Publications.png?width=44&height=49&name=Icon_Publications.png) #### Publications Becker, RHA., et al., 2015. New insulin glargine 300 units/mL provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units/mL. Diabetes Care 38:637-643, 2015. [View all](https://www.profil.com/knowledge-center/publications?hsLang=zh) The Profil Institute for Metabolic Research supports the **clinical development** of the full range of diabetes medication and instrumentation. Our services include clinical trials of antidiabetic drugs, insulin alternatives and personalized diabetes treatments and full support for insulin development. Clinical trials for diabetes drugs are possible thanks to our extensive experience with the methodologies necessary for this type of pharma development. We stand ready to act as pharmaceutical research associates to all institutions engages in diabetes treatment development. ###### Profil Institut für Stoffwechselforschung GmbH Hellersbergstraße 9 · 41460 - Neuss, Germany Telefon +49-2131-4018-345 · marketing@profil.com [Imprint](https://www.profil.com/imprint?hsLang=zh) | [Privacy Policy](https://www.profil.com/privacy?hsLang=zh)